Skip to main content

Bioaccess Ivs

4 CVEs product

Monthly

CVE-2023-38958 MEDIUM This Month

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Authentication Bypass Bioaccess Ivs
NVD VulDB
CVSS 3.1
5.3
EPSS
0.3%
CVE-2023-38956 HIGH This Week

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Path Traversal Bioaccess Ivs
NVD VulDB
CVSS 3.1
7.5
EPSS
0.6%
CVE-2023-38955 HIGH This Week

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure Bioaccess Ivs
NVD VulDB
CVSS 3.1
7.5
EPSS
0.5%
CVE-2023-38954 CRITICAL Act Now

ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

SQLi Bioaccess Ivs
NVD VulDB
CVSS 3.1
9.8
EPSS
0.5%
EPSS 0% CVSS 5.3
MEDIUM This Month

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Authentication Bypass Bioaccess Ivs
NVD VulDB
EPSS 1% CVSS 7.5
HIGH This Week

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Path Traversal Bioaccess Ivs
NVD VulDB
EPSS 1% CVSS 7.5
HIGH This Week

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure Bioaccess Ivs
NVD VulDB
EPSS 1% CVSS 9.8
CRITICAL Act Now

ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

SQLi Bioaccess Ivs
NVD VulDB

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy